Tirzepatide Weight Loss Injections
Tirzepatide, sold under the brand name Mounjaro® or Zepbound, is the newest injectable drug in a group of drugs called GLP-1 receptor. It was FDA approved for the treatment of type 2 diabetes and is now approved for weight loss. In addition to it’s effects on blood sugar and insulin levels, studies have shown that Mounjaro®(tirzepatide) provided substantial and sustained weight loss.
How Does it Work?
- Decreases food intake – reduces how much food is eaten
- Increases insulin sensitivity – helping the body release insulin when blood sugar is high
- Enhances first and second phase insulin secretion – helps the body remove excess sugar from the blood
- Slows gastric emptying – slows down how quickly food leaves the stomach (this will lessen over time)
- Reduces glucagon levels – stops the liver from making and releasing too much sugar
What is the difference between tirzepatide and semaglutide?
GLP-1 drugs (such as Mounjaro/ Zepbound®, Ozempic®, and Wegovy™) are a group of new drugs that mimic GLP-1, a hormone the body releases after a meal, signaling you are full and lowering appetite. However, Mounjaro®(tirzepatide) is unique because it attaches to two different receptors (GLP-1 and GIP), unlike previous GLP-1 analogs, which only attach to one. Due to it’s unique dual activity, Mounjaro®(tirzepatide) has shown about 50% better weight loss than Ozempic® and Wegovy™.
Our Tirzepatide Injection contains the same active ingredient as Mounjaro making it the ‘generic’ version of the brand name medication. What differs is that our injection comes compounded with Methylcobalamin b12 in a vial to be drawn up into insulin syringes, whereas the brand name medication comes in a pre-loaded pen.
Our weight loss medication, tirzepatide, is also much more cost effective than the brand name medication which can range from $500-1500 per month – versus ours which starts at only $250
